Quality Outlook: Discern and the Journal of Clinical Pathways Launch a New Blog Series

September 2019

Tom Valuck, MD, JD
Tom Valuck, MD, JD

Discern Health and the Journal of Clinical Pathways (JCP) have launched a new oncology-focused commentary series, Quality Outlook. The series, authored by JCP editorial board member and Discern Partner Tom Valuck and other Discern subject matter experts, explores key issues related to oncology quality and value, such as measurement, value-based payment, and quality improvement of care.

The first installment of the series, “Oncology Quality Measurement: Angst and Ambition,” examines the need for value-based solutions and adequate value assessment measurements to ensure that high-quality outcomes are obtained from cancer care costs. Stay tuned for more installments in the coming months.

Read the first post here.

Learn more about the series here.

New Report: Recommendations for Patient and Family Engagement in Measure Development

Harnessing the stories, ideas, and innovations of patient and caregiver partners is the key to making measurement meaningful. With support from the Patient-Centered Outcomes Research Institute (PCORI)...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO